Reversible alopecia universalis during treatment with PEG-interferon and ribavirin for chronic hepatitis C

Journal of Chemotherapy

Volumn 17, Issue 2, 2005, Pages 212-214

  Taliani, G ^a,b   Biliotti, E ^a   Capanni, M ^a   Tozzi, A ^a   Bresci, S ^a   Pimpinelli, N ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Alopecia universalis; Chronic hepatitis C; Hepatitis C; PEG interferon; Ribavirin

Indexed keywords

ANTIDEPRESSANT AGENT; CORTICOSTEROID; FERRITIN; LORAZEPAM; PEGINTERFERON ALPHA2A; RIBAVIRIN; SERTRALINA; UNCLASSIFIED DRUG;

ADULT; ALOPECIA; ANAMNESIS; ARTICLE; CASE REPORT; CHRONIC DISEASE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DEPRESSION; DRUG WITHDRAWAL; ECZEMA; FEMALE; GENOTYPE; HAIR GROWTH; HAIR LOSS; HEART PALPITATION; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IRRITABILITY; NEUTROPENIA; PHYSICAL EXAMINATION; PRURITUS; RELAPSE; SIDE EFFECT; TACHYCARDIA; THYROID DISEASE; TREATMENT OUTCOME;

EID: 19544383191     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2005.17.2.212     Document Type: Article

References (17)

1. Strader DB, Wright T, Thomas DL, Seef LB. Diagnosis, Management, and Treatment of Hepatitis C. Hepatology 2004; 39: 1147-1171.
2. Russo MW, Fried MW. Side Effects of therapy for chronic hepatitis C. Gastroenterology 2003; 124:1711-1719.
3. Struiek-Kaminska D, Ochsendorf F, Roder C, Wolter M, Zeuzem S. Photoallergic skin reaction to ribavirin. Am J Gastroenterol 1999; 94:1686-1688.
4. Sookian S, Neglia V, Castano G, Frider B, Kien MC, Chohuela E. High prevalence of cutaneous reactions to interferon alpha plus ribavirin combination therapy in patients with chronic hepatitis C. Arch Dermatol 1999; 135:1000-1001.
5. Cottoni F, Bolognini S, Deplano A, et al. Skin reaction in antiviral therapy for chronic hepatitis C: a role for polyethylene glycol interferon? Acta Derm Venereol 2004; 84: 120-123.
6. Fleming CJ, MacKie RM. Alpha interferon induced hair discolouration. Br J Dermatol 1996; 135:337-338.
7. Misery L. Diffuse hypertrichosis in the course of hepatitis C treatment by IFN-alpha and ribavirin. J Interferon Cytokine Res 2002; 22: 881-882.
8. Tosti A, Misciali C, Bardazzi F, Fanti PA, Varotti C. Telogen effluvium due to recombinant interferon alfa-2b. Dermatology 1992; 184: 124-125.
9. Agesta N, Zabala R, Diaz-Perez JL. Alopecia areata during interferon alfa-2b/ribavirin therapy. Dermatology 2002; 205: 300-301.
10. Alexis AF, Dudda-Subramanya R, Sinha AA. Alopecia Areata: autoimmune basis of hair loss. Eur J Dermatol 2004; 14 (36): 364-370.
11. Area E, Musabak U, Akar A, Erbil AH, Tastan HB. Interferon-gamma in alopecia areata. Eur J Dermatol 2004; 14 (1): 33-6.
12. Teraki Y, Imanishi K, Shiohara T. Cytokines in Alopecia Areata: contrasting cytokine profiles in localized form and extensive form (Alopecia Universalis). Acta Derm Venereol 1996; 76: 421-423.
13. Lang AM, Norland AM, Schuneman RL, Tope WD. Localized interferon alfa-2b induced alopecia. Arch Dermatol 1999; 135:1126-1128.
14. Manjon-Haces JA, Vazquez-Lopez F, Gornez-Diez S, et al. Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus. Acta Derm Venereol 2001; 81: 223.
15. Fisher AA. Immediate and delayed allergic contact reactions to polyethylene glycol. Contact Dermatitis 1978; 4: 135-138.
16. Colombe BW, Lou CD, Price VH. The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis. J Investig Dermatol Symp Proc 1999; 4 (3): 216-9.
17. Ruiz-Doblado S, Carrizosa A, Garcia-Hernandez MJ. Alopecia areata: psychiatric comorbidity and adjustment to illness. Int J Dermatol 2003; 42: 434-437.